Randall Barton
Technik-/Wissenschafts-/F&E-Leiter bei NANOVIRICIDES, INC.
Profil
Randall W.
Barton's current job is as the Chief Scientific Officer at NanoViricides, Inc. Dr. Barton's former jobs include being the Director-Invitro Cardiovascular Researchat at Boehringer Ingelheim Pharmaceuticals, Inc., Vice President-Drug Discovery at A&G Pharmaceutical, Inc., Principal at the University of Connecticut, and Chief Scientific Officer at Kard Scientific, Inc. Dr. Barton's education history includes an undergraduate degree from Indiana University and a doctorate degree from the University of Tennessee.
Aktive Positionen von Randall Barton
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOVIRICIDES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.03.2010 |
Ehemalige bekannte Positionen von Randall Barton
| Unternehmen | Position | Ende |
|---|---|---|
Kard Scientific, Inc.
 Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| University of Connecticut | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
A&G Pharmaceutical, Inc.
 A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Corporate Officer/Principal | - |
Ausbildung von Randall Barton
| Indiana University | Undergraduate Degree |
| University of Tennessee | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NANOVIRICIDES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Kard Scientific, Inc.
Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Commercial Services |
